Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic.
Do Flexible Goal Adjustment and Acceptance Help Preserve Quality of Life in Patients with Multiple Sclerosis?
Optimizing treatment success in multiple sclerosis.
Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.
Spinal cord lesions and disability in Hispanics with multiple sclerosis.
Any role for probiotics in the therapy or prevention of autoimmune diseases? Up-to-date review.
The Treatment of Tremor.
[Research status on the epidemiological characteristics of optic neuritis].
Restless legs syndrome associated with major diseases: A systematic review and new concept.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.
Molecular genetic studies of multiple sclerosis in the portuguese population.
Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely.
Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.
Acute transverse myelitis (ascending myelitis) as the initial manifestation of Japanese encephalitis: a rare presentation.
Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
[The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis.]
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ.
How embodied is action language? Neurological evidence from motor diseases.
Defining a role for laquinimod in multiple sclerosis.

Pages